Alessandro Oteri

Alessandro Oteri

Auto-generated profile, based on publicly available information

Alessandro Oteri

University of Messina

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2010 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
AOAlessandro Oteri
Alessandro Oteri
GTGianluca Trifirò
Gianluca Trifirò
MGMaria Silvia Gagliostro
Maria Silvia Gagliostro
Daniele Ugo TariDaniele Ugo Tari
Daniele Ugo Tari
SMSalvatore Moretti
Salvatore Moretti
VAVincenzo Arcoraci
Vincenzo Arcoraci
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• In the last years there has been a growing trend in anti‐epileptic drug (AED) use, particularly in elderly patients, but few data concerning indication of use are available in general practice.• Various AEDs, including newer agents, have been approved for indications other than epilepsy and are increasingly also used for unlicensed indications.• No data about the impact of re‐imbursement restrictions on the choice of anti‐epileptic drugs in general practice are available.WHAT THIS STUDY ADDS• In general practice, a rapid increase of AED prescriptions in the elderly was observed, principally due to the use of newer AEDs for indications other than epilepsy.• Re‐imbursement restrictions influenced newer AED use, particularly pregabalin and gabapentin prescriptions.• Phenobarbital, accounting for more than 50% of total AED volume, was the most prescribed medication during the entire study period. This finding should be considered in light of the potential risks associated with phenobarbital use in the geriatric population.AIMS: The aims of the study were to assess the trend of older and newer anti‐epileptic drugs (AEDs) in the elderly population and to analyze the effects of a health‐policy intervention with regard to AED use in general practice in a setting in Southern Italy.METHODS: Data were extracted from the ‘Caserta‐1’ Local‐Health‐Unit Arianna database in the years 2004–07. Patients aged over 65 years, receiving at least one AED prescription and registered in the lists of 88 general practitioners, were selected. The use of older and newer AEDs was calculated as 1 year prevalence and incidence of use and defined daily dose (DDD) per 1000 inhabitants day−1. Sub‐analyses by gender, age and indication of use were performed.RESULTS: Most of AED users were treated because of neuropathic pain (64.8%). However, the main indication of use for older AEDs (57.8%) was epilepsy, whereas newer AEDs (79.5%) were used for neuropathic pain. Prevalence and incidence of newer AED use increased until 2006, followed by a reduction in 2007. Newer AEDs, particularly gabapentin and pregabalin, were used in the treatment of more patients than older AEDs. However phenobarbital, accounting for more than 50% of total AED volume, was the most prescribed medication during the entire study period.CONCLUSIONS: An increasing use of AEDs has been observed during 2004–07, mostly due to the prescription of newer compounds for neuropathic pain. The fall in the use of newer AEDs during 2007 coincides with revised re‐imbursement criteria for gabapentin and pregabalin. The large use of phenobarbital in the elderly should be considered in the light of a risk of adverse drug reactions.

1 November 2010 in Pediatrics
Verified
Journal Article
Closed access
PDF file
AOAlessandro Oteri
Alessandro Oteri
ABAnna Bussolini
Anna Bussolini
MSMilena Sacchi
Milena Sacchi
ECEmilio Clementi
Emilio Clementi
Gianvincenzo ZuccottiGianvincenzo Zuccotti
Gianvincenzo Zuccotti
SRSonia Radice
Sonia Radice
Atrial fibrillation (AF) is the most common rhythm disorder observed in clinical practice. Several case reports and case-control studies have associated this condition with the use of systemic corticosteroids. However, to our knowledge, no case of AF induced by inhaled corticosteroids has been reported in the literature. We describe here the case of a 15-year-old boy who reported a paroxysmal AF with fast ventricular response after the administration of fluticasone propionate, which resolved after discontinuation of the drug. Use of the Naranjo adverse-drug-reaction probability scale indicated a possible relationship between the patient's development of AF and fluticasone propionate therapy. More studies are needed to confirm the association between this arrhythmia and the use of high doses of inhaled corticosteroids. Data from this report already suggest that clinicians should be aware of the possibility of adverse cardiovascular reactions when corticosteroids are prescribed also as inhaled preparations.

1 January 2007 in Drug Safety
Verified
Journal Article
Closed access
PDF file
MCM A Catania
M A Catania
PCP. Caiello
P. Caiello
AOA. Oteri
A. Oteri
GPG. Polimeni
G. Polimeni
ARA Russo
A Russo
ACA. P. Caputi
A. P. Caputi

1 January 2007 in Drug Safety
Verified
Journal Article
Closed access
PDF file
AOA. Oteri
A. Oteri
LGL. Giacci
L. Giacci
MCM A Catania
M A Catania
GPG. Polimeni
G. Polimeni
ARA. Russo
A. Russo
ACA. P. Caputi
A. P. Caputi

1 January 2007 in Drug Safety
Verified
Journal Article
Closed access
PDF file
GPG. Polimeni
G. Polimeni
ARA. Russo
A. Russo
MCM A Catania
M A Catania
GTG. Trifirò
G. Trifirò
CCC. Cupani
C. Cupani
ACA. P. Caputi
A. P. Caputi